Massaro, Monica
Harvard University · University of California, San Francisco · VA Boston Healthcare System · Massachusetts General Hospital · Dana-Farber Cancer Institute · Bluebird Bio (United States) · Harold C. Simmons Comprehensive Cancer Center · The University of Texas Southwestern Medical Center · Icahn School of Medicine at Mount Sinai
3 papers on CoChat
Most cited papers
- Verified
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
Munshi, N. C., Anderson, L. D., Shah, N., Madduri, D., Berdeja, J., Lonial, S., Raje, N., Lin, Y., Siegel, D., Oriol, A., et al. (2021) · New England Journal of Medicine
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 2,560
- Verified
Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma.
Raje, N., Berdeja, J., Lin, Y., Siegel, D., Jagannath, S., Madduri, D., Liedtke, M., Rosenblatt, J., Maus, M. V., Turka, A., et al. (2019) · New England Journal of Medicine
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 1,730
- Verified
Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective α7 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies.
Barbier, A. J., Hilhorst, M., Vliet, A. V., Snyder, P., Palfreyman, M. G., Gawryl, M., Dgetluck, N., Massaro, M., Tiessen, R., Timmerman, W., et al. (2015) · Clinical Therapeutics
Nicotinic Acetylcholine Receptors StudyAlzheimer's disease research and treatments
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free